arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Disc Medicine, Inc.

IRON

$78.36 ▼ -4.76 (-5.73%) at close

7 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bearish

auto_awesome

Analytical Summary

Disc Medicine, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $2.8B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -30.7% ↘

FCF / Share $-5.14 ↘

Trailing P/E —

Price / Book 4.0x

FCF Yield —

Debt / Equity 0.04

info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-212.18M

↓ -94.0% —

FCF / Share Free cash flow per share

$-5.14

↓ -50.2% —

Long-Term Debt Long-term obligations

$29.16M

↑ +3.0% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	-51.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-15.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	92.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-10.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	-94.0% Weak ↓ Weak Declining Year-over-year change in net income	-43.1% Weak ↓ Weak Declining Year-over-year change in net income	-63.2% Weak ↓ Weak Declining Year-over-year change in net income	-30.2% Weak Weak Year-over-year change in net income	11.9% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%)	-50.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	-3.8% Weak ↓ Weak Declining Year-over-year change in free cash flow	91.9% Excellent Excellent Year-over-year change in free cash flow	-29.8% Weak Weak Year-over-year change in free cash flow	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
FCF / Net Income (x)	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-30.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	38.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	342.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-29.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-24.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-409.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-28.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-291%)	-24.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-264%)	-22.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-248%)	-26.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-277%)	56.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+273%)	186.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1145%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	-0.64x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-207%)	—
Interest Coverage (x)	-84.44x Weak Weak Operating income divided by interest expense Optimal: > 5x	-655.15x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-4.99x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-61.99M	$-164.11M	$-360.38M	$-194.61M	$-88.04M	$9.50M	—
Debt / EBITDA (x)	-0.12x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.22x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-0.42x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-6.01	$-3.96	$-3.42	$-45.05	$-40.95	—	—
Free Cash Flow per Share (USD)	$-5.14	$-3.42	$-3.30	$-40.79	$-31.42	—	—
Book Value per Share (USD)	$19.53	$14.85	$14.17	$10.15	$-70.60	$-1.40	—
Tangible Book Value per Share (USD)	$19.53	$14.85	$14.17	$10.15	$-70.60	$-1.40	—
Basic Weighted Avg Shares (shares)	35.30M	27.61M	22.32M	1.04M	878,407	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$767.26M	$470.30M	$344.22M	$175.91M	$77.06M	$-19.81M	—
LT Debt (USD)	$29.16M	$28.32M	$0.00	—	—	$14.00M	—
Total Equity (USD)	$739.83M	$443.59M	$345.12M	$176.60M	$-64.20M	$-21.86M	$-10.43M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$281.00K	$156.00K	$100.00K	$89.00K	$32.00K	$322.00K	—
Net Income, GAAP (USD)	$-212.18M	$-109.36M	$-76.43M	$-46.83M	$-35.97M	$-40.84M	—
Operating Cash Flow (USD)	$-180.39M	$-93.93M	$-73.46M	$-42.25M	$-27.53M	$-32.71M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters

Disc Medicine, Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IRON with peers